162 related articles for article (PubMed ID: 35533023)
1. Consistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery.
Horeczko J; Hendi A
J Drugs Dermatol; 2022 May; 21(5):506-509. PubMed ID: 35533023
[TBL] [Abstract][Full Text] [Related]
2. Application of Mohs micrographic surgery appropriate-use criteria to skin cancers at a university health system.
Blechman AB; Patterson JW; Russell MA
J Am Acad Dermatol; 2014 Jul; 71(1):29-35. PubMed ID: 24813300
[TBL] [Abstract][Full Text] [Related]
3. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
Cumberland L; Dana A; Liegeois N
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
[TBL] [Abstract][Full Text] [Related]
4. Mohs Micrographic Surgery for Genital Skin Cancer: A Review of Cases and Reconstructive Techniques.
Zhu TH; Zhu TR; Routt E; Ciocon D
J Drugs Dermatol; 2021 Mar; 20(3):311-319. PubMed ID: 33683082
[TBL] [Abstract][Full Text] [Related]
5. Mohs micrographic surgery for cutaneous lymphadenoma.
Hanlon A; Clayton A; Stasko T
Dermatol Surg; 2012 Sep; 38(9):1552-4. PubMed ID: 22676375
[TBL] [Abstract][Full Text] [Related]
6. Mohs Micrographic Surgery in Skin of Color.
Williams R; Ciocon D
J Drugs Dermatol; 2022 May; 21(5):536-541. PubMed ID: 35533042
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Accuracy of Patient and Physician Scar Length Estimates Before Mohs Micrographic Surgery for Facial Skin Cancers.
Fix WC; Miller CJ; Etzkorn JR; Shin TM; Howe N; Sobanko JF
JAMA Netw Open; 2020 Mar; 3(3):e200725. PubMed ID: 32159810
[TBL] [Abstract][Full Text] [Related]
9. Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution.
Krishnan A; Xu T; Hutfless S; Park A; Stasko T; Vidimos AT; Leshin B; Coldiron BM; Bennett RG; Marks VJ; Brandt R; Makary MA; Albertini JG;
JAMA Dermatol; 2017 Jun; 153(6):565-570. PubMed ID: 28453605
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery for periocular skin tumours in Ireland.
Treacy MP; Wynne NC; Gale JL; Duignan E; Moran B; Flynn AM; Ormond P; Barry R; Khan R; Moriarty P; Cassidy L
Ir J Med Sci; 2016 Nov; 185(4):779-783. PubMed ID: 26159430
[TBL] [Abstract][Full Text] [Related]
12. Impact of the COVID Pandemic on Mohs Micrographic Surgery: A Nationwide Survey.
Seger E; Neill B; Hocker T; Ibrahimi O
J Drugs Dermatol; 2022 May; 21(5):545-547. PubMed ID: 35533028
[TBL] [Abstract][Full Text] [Related]
13. Mohs micrographic surgery for cutaneous malignancies: A focus review of its indications in pediatric age groups.
Le ST; Kamal HY; Khachemoune A
Pediatr Dermatol; 2018 Jul; 35(4):434-440. PubMed ID: 29575263
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
15. MMS hotspots: a cross-sectional comparison of U.S. counties with and without Mohs micrographic surgery.
Sharma AN; Peterman N; Juhasz M; Shive M
Arch Dermatol Res; 2023 Dec; 316(1):21. PubMed ID: 38060044
[TBL] [Abstract][Full Text] [Related]
16. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
17. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
18. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
20. Eighteen years of experience in Mohs micrographic surgery and conventional excision for nonmelanoma skin cancer treated by a single facial plastic surgeon and pathologist.
van der Eerden PA; Prins ME; Lohuis PJ; Balm FA; Vuyk HD
Laryngoscope; 2010 Dec; 120(12):2378-84. PubMed ID: 21046543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
